Natália Melo 1
Carla Damas 2
Conceição Souto Moura 3
António Morais 2
Resumo
Alguns doentes com fibrose pulmonar idiopática (FPI) apresentam durante a sua evolução fases deagravamento clínico sem causa conhecida, designadas como “exacerbação aguda” ou “fase acelerada” da doença (EA). Caracterizam -se pelo agravamento marcado da dispneia, hipoxemia e pelo aparecimento de novas opacidades pulmonares ou pelo agravamento das já existentes no estudo imagiológico. Os achados histológicos típicos são o dano alveolar difuso (DAD) sobreposto a alterações de pneumonia intersticial usual (UIP). Esta entidade clínica associa -se a uma mortalidade elevada, não havendo até ao momento nenhuma terapêutica de comprovada eficácia.
]]> Os autores descrevem os casos clínicos de cinco doentes que apresentaram alterações clínicas, funcionais e radiológicas sugestivas de EA-FPI, assim como o tratamento efectuado e a evolução observada, enquadrando-os na discussão das características normalmente apresentadas por esta entidade.Palavras -chave: Fibrose pulmonar idiopática, exacerbação aguda.
Acute exacerbation of idiopathic pulmonary fibrosis
Abstract
Some patients with Idiopathic Pulmonary Fibrosis (IPF) have disease accelerated deterioration without identifiable cause referred as “acute exacerbation” or “accelerated stage”. It is characterized by severe worsening of dyspnea, hypoxemia and new or progressive opacities on imaging studies. The typical histological findings are diffuse alveolar damage in addition to the features of usual interstitial pneumonia pattern. Mortality in this clinical entity is very high and no efficacious therapeutic have been described.
The authors describe the clinical, functional and radiological features, treatment and evolution of five patients with IPF acute exacerbation. A discussion will be carry out concerning the IPF acute exacerbation usual features comparing with the alterations noticed in those patients.
Key words: Idiopathic pulmonary fibrosis, acute exacerbation.
]]>
Texto completo disponível apenas em PDF.
Full text only available in PDF format.
Bibliografia
1. Kim DS, Collard HR, King TE Jr. Classification and natural history of idiopathic interstitial pneumonias. The proceedings of the American Thoracic Society 2006; 3:285 -292. [ Links ]
2. Smith C, Feldman C, Levy H, et al. Cryptogenic fibrosing alveolitis: a study of an indigenous African population. Respiration (Herrlisheim) 1990; 57:364-371.
3. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157:1301 -1315
4. American Thoracic Society / European Respiratory Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International Consensus Statement. Am J Respir Crit Care Med 2000; 161:646 -664.
]]> 5. Panos RJ, Mortenson R, Niccoli SA, et al. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med 1990; 88:396 -404.6. Kondoh Y, Taniguchi H, Kawabata Y, et al. Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathologic findings in three cases. Chest 1993; 103: 1808 -1812.
7. Akira M, Hamada H, Sakatani M, et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am J Roentgenol 1997; 168:79 -83.
8. Ambrosini V, Cancellieri A, Chilosi M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J 2003; 22:821 -826.
9. Martinez FJ, Safrin S, Weycker D, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005; 142:963 -967.
10. Azuma A, Nukwa T, Tsuboi E, et al. Double –blind placebo -controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005; 171:1040 -1047.
11. Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Resp J 2006; 27:143 -150.
12. Hiwatari N, Shimura S, Takishima T, et al. Bronchoalveolar lavage as a possible cause of acute exacerbation in idiopathic pulmonary fibrosis patients. Tohoku J Exp Med 1994; 174:379 -386.
13. Kondoh Y, Taniguchi H, Kitaichi M, et al. Acute exacerbation of idiopathic pulmonary fibrosis following surgical lung biopsy. Respir Med 2006; 100:1753 -1759.
14. Yüksel M, Özyurtkan MO, Bostanci K, et al. Acute exacerbation of interstitial fibrosis after pulmonary resection. Ann Thorac Surg 2006; 82:336 -338.
]]> 15. Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest 2005; 128:3310 -3315.16. Dallari R, Foglia M, Paci M, Cavazza A. Acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir J 2004; 23:792.
1 Interna Complementar de Pneumologia
2 Assistente Hospitalar de Pneumologia
Serviço de Pneumologia do Hospital S. João – Director de Serviço: Prof. Dr. Venceslau Hespanhol
3 Assistente Hospitalar Graduada de Anatomia Patológica
Serviço de Anatomia Patológica do Hospital S. João – Directora de Serviço: Prof. Dra. Fátima Carneiro
]]> Correspondência/Correspondence to:
Natália Melo
Serviço de Pneumologia, Hospital de S. João
Alameda Professor Hernâni Monteiro
4202-451 Porto
Telefone: 919371855
e -mail: nataliafmelo@hotmail.com
Recebido para publicação/received for publication: 08.04.11
Aceite para publicação/accepted for publication: 08.11.07
]]>